Full-Time

Medical Director

Diagnostic Cardiology

Posted on 11/1/2025

GE Healthcare

GE Healthcare

1-10 employees

Imaging, monitoring, and healthcare IT solutions

No salary listed

Chicago, IL, USA + 1 more

More locations: Waukesha, WI, USA

Hybrid

Hybrid: three days on-site weekly in Chicago or Waukesha; 10-15% travel; relocation assistance provided.

US Top Secret Clearance Required

Category
Medical, Clinical & Veterinary (1)
Required Skills
Word/Pages/Docs
Marketing
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Medical Degree and US board certification in Cardiology with a minimum of 2 years of post-training clinical experience
  • Excellent presentation, verbal, and written communication skills with the ability to communicate clinical and business issues to audiences of diverse backgrounds
  • Strong leadership skills: able to create a dynamic environment that fosters transparency, collaboration, and innovative thinking
  • Strong problem solving and negotiation skills; ability to influence and make recommendations at multiple levels of the company
  • Minimum of 5 years of project management skills to establish strategic goals and to prioritize, plan, delegate and evaluate deliverables
  • Experience working with Microsoft Office products (Outlook, Word, Excel, PowerPoint)
  • Hybrid work schedule with three days per week on-site in the Chicago or Waukesha GEHC offices
  • Ability to travel 10-15% of the time (domestic and international)
Responsibilities
  • Champion voice of the customer to drive innovation in alignment with DCAR business strategy including a focus on AI-ECG advances
  • Develop a vision for AI-ECG opportunities and the impact on clinicians, patients, and workflow, with alignment among stakeholders in DCAR, PCS, and the GEHC enterprise
  • Serve as the key clinical advisor to the General Manager (GM) of DCAR by providing strategic guidance on new technologies and cardiology workflow innovation
  • Provide Medical leadership in development of the core technologies for DCAR including resting, stress and ambulatory ECG systems that are in the DCAR portfolio now or in the future
  • Steer collaborative efforts between business leaders and research team to define bench and human clinical research priorities for product development, regulatory submissions, and marketing, based on intended clinical applications, business, and regulatory strategy
  • Establish and cultivate strategic academic partners suited for GEHC research and innovation partnerships. Work with collaborators and product teams to solicit investigator-initiated research proposals that are aligned with DCAR research needs including specific disease states
  • Lead and own the global strategies for health economics, policy, and reimbursement (HEPR) for DCAR solutions
  • Build, sustain and serve as the leader for influential relationships with Key Opinion Leaders (KOLs) to drive scientific exchange and shape the future of DCAR technologies
  • Communicate and translate clinical/scientific insights and research concepts from KOLs into actionable guidance for product development teams
  • Strategically support the development and execution of pre-launch product initiatives, commercialization, and life cycle management of DCAR products through education, innovation, evidence generation and research
  • Prepare and deliver training on new industry campaigns and clinical evidence as well as work with the DCAR marketing team on providing clinical input in campaigns, insights articles and other outreach
  • Manage medical inquiries from health care providers as needed by the DCAR GM or product management team
  • Present clinical evidence to regional and national meetings of professional societies
  • Manage medical materials for regulatory, marketing, and commercial activities
  • Lead medical reviews of promotional and scientific materials to ensure compliance with applicable regulations and clinical accuracy
  • Provide Medical inputs throughout the development and implementation of clinical evaluations and/or clinical studies
  • Writes/manages scientific papers for publication by evaluating scientific literature, analyzing scientific data and staying abreast of current clinical practice
Desired Qualifications
  • 10+ years of product and domain knowledge of healthcare technologies and market trends
  • 8+ years’ experience working in the medical technology, medical device, or pharmaceutical industry in Medical or Clinical Affairs roles
  • MBA or Masters degree in business related field
  • Has extensive clinical experience and a knowledge base beyond cardiology that extends to complementary areas within the PCS business such as digital health, anesthesia systems, and patient monitoring technologies
  • Experience in clinical research roles in academia, healthcare, life sciences, or a medical technology business
  • Direct experience utilizing AI technology in the clinical environment with an understanding of obstacles to adoption
  • Participation as a principal investigator or sub-investigator in human subject research projects in industry and investigator sponsored trials
  • Familiarity with regulatory and risk management standards for US and global markets
  • Demonstrated problem-solving abilities, demonstrated success leading cross-functional projects and working with global team members
  • Experience delivering conference presentations, moderating symposia and webinars
  • Authorship of peer reviewed publications

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Simplify Jobs

Simplify's Take

What believers are saying

  • $2.3B Intelerad acquisition boosts cloud imaging amid $5.1B Q1 2026 revenue.
  • DeepHealth AI partnership lifts breast cancer detection 21% globally.
  • $21.8B backlog and supply chain shifts sustain 3-4% organic growth.

What critics are saying

  • Siemens Cios Alpha erodes CT share with superior resolution by Q2 2027.
  • Canon Vantage Galan captures MRI contracts 20-30% cheaper in 6-12 months.
  • FTC probe forces Intelerad divestitures, costing $300-500M by Q1 2027.

What makes GE Healthcare unique

  • GE HealthCare's four divisions span imaging, ultrasound, patient care, and pharmaceutical diagnostics.
  • Bangalore's $50M R&D center drives innovations across 100+ countries.
  • Photonova Spectra's Deep Silicon detectors enable 8-bin energy resolution CT imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Relocation Assistance

Company News

The Associated Press
Apr 9th, 2026
GE HealthCare integrates bkActiv ultrasound with Medtronic Stealth AXiS for real-time cranial surgery navigation

GE HealthCare has announced a digital integration between its bkActiv intraoperative ultrasound system and Medtronic's Stealth AXiS surgical navigation system, now commercially available for cranial procedures. The integration allows neurosurgeons to use bkActiv as a plug-and-play real-time visualisation solution during procedures. The system addresses "brain shift", a natural movement of the brain during surgery that reduces pre-surgical image accuracy. bkActiv provides live ultrasound images alongside pre-operative MRI or CT scans on the Stealth AXiS system, recently cleared by the FDA for cranial procedures in the United States. Features include sterilisable transducers, sensitive colour Doppler for blood flow visualisation, and remote control capability from the sterile field. The companies will showcase the integration at the American Association of Neurological Surgeons Annual Scientific Meeting in May 2026.

Business Wire
Mar 25th, 2026
GE HealthCare unveils photon-counting CT and ReadyFix fleet management at ACC.26

GE HealthCare is showcasing its cardiology portfolio at ACC.26, featuring AI-enabled imaging technologies and software solutions addressing cardiovascular disease, which kills over 900,000 Americans annually. The company received US FDA 510(k) clearance for Photonova Spectra, a photon-counting CT system with proprietary Deep Silicon detectors designed to provide ultra-high-definition cardiac imaging and improved plaque characterisation. GE HealthCare introduced ReadyFix fleet management solution for MAC VU360 ECG workstations, enabling remote diagnostics and software deployment to optimise device uptime. The company also announced a US collaboration with Gentuity, connecting customers with HF-OCT and Vis-Rx PRIME Micro-Imaging Catheter for enhanced coronary procedure visualisation. The $20.6 billion company serves patients globally with imaging, diagnostics and AI solutions across the cardiology care pathway.

Business Wire
Mar 23rd, 2026
GE HealthCare's photon-counting CT Photonova Spectra receives FDA clearance

GE HealthCare has received FDA 510(k) clearance for Photonova Spectra, a photon-counting computed tomography system powered by its Deep Silicon detector technology. The system directly counts individual photons and measures their energy, enabling higher spectral and spatial resolution compared to conventional CT systems that first convert X-rays into visible light. Photonova Spectra features 8-bin energy resolution, wide detector coverage and rapid 0.23-second rotation speed, supporting fast acquisition and detailed visualisation across multiple clinical specialties. The system automatically captures spectral and ultra-high definition spatial data simultaneously without requiring special protocols. The technology incorporates NVIDIA accelerated computing to process up to 50 times more data than conventional CT systems. GE HealthCare is collaborating with institutions including UW-Madison and Stanford Medicine to explore clinical applications and imaging protocols.

Yahoo Finance
Mar 17th, 2026
GE HealthCare appoints Stryker CEO Kevin Lobo to board of directors

GE HealthCare has appointed Kevin Lobo, chair and CEO of Stryker Corporation, to its board of directors effective 13 March. Lobo brings over 25 years of medical technology, operational and financial leadership experience to the role. Lobo has served as Stryker's CEO since October 2012 and board chair since July 2014. Previously, he held leadership positions at Johnson & Johnson, including president of Ethicon Endo Strategy, and at chemical and pharmaceutical company Rhône-Poulenc. His early career included finance roles at KPMG, Unilever and Kraft Canada. GE HealthCare chairman H. Lawrence Culp said Lobo's clinical expertise and track record of driving innovation would strengthen the board as the company pursues growth priorities in personalised, connected healthcare.

Yahoo Finance
Mar 16th, 2026
Arthur J. Gallagher leads with 17.9% revenue growth while Grand Canyon Education and GE HealthCare struggle

Arthur J. Gallagher, an insurance brokerage and consulting firm, stands out amongst cash-producing stocks with a 12.8% trailing 12-month free cash flow margin. The company has demonstrated strong revenue growth of 17.9% annually over the past two years and earnings per share growth of 17.7% annually over five years, outperforming peers. In contrast, Grand Canyon Education faces challenges with underwhelming student numbers and modest earnings growth of just 7.2% annually over five years, despite a 21.6% free cash flow margin. GE HealthCare also struggles with weak 2.7% annual revenue growth over two years and limited organic expansion. Arthur J. Gallagher, operating in approximately 130 countries, provides insurance brokerage, reinsurance and consulting services globally.

INACTIVE